Connection

John Gross to Humans

This is a "connection" page, showing publications John Gross has written about Humans.
Connection Strength

0.336
  1. The structural basis for HIV-1 Vif antagonism of human APOBEC3G. Nature. 2023 Mar; 615(7953):728-733.
    View in: PubMed
    Score: 0.033
  2. Structural Basis for a Species-Specific Determinant of an SIV Vif Protein toward Hominid APOBEC3G Antagonism. Cell Host Microbe. 2019 12 11; 26(6):739-747.e4.
    View in: PubMed
    Score: 0.026
  3. Conformational Dynamics of the HIV-Vif Protein Complex. Biophys J. 2019 04 23; 116(8):1432-1445.
    View in: PubMed
    Score: 0.025
  4. Decapping enzymes STOP "cancer" ribosomes in their tracks. EMBO J. 2018 12 03; 37(23).
    View in: PubMed
    Score: 0.024
  5. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog. 2018 01; 14(1):e1006830.
    View in: PubMed
    Score: 0.023
  6. CBF? and HIV Infection. Adv Exp Med Biol. 2017; 962:415-431.
    View in: PubMed
    Score: 0.021
  7. Molecular biology: Messenger RNAs marked for longer life. Nature. 2017 01 19; 541(7637):293-294.
    View in: PubMed
    Score: 0.021
  8. Structural basis of mRNA-cap recognition by Dcp1-Dcp2. Nat Struct Mol Biol. 2016 Nov; 23(11):987-994.
    View in: PubMed
    Score: 0.021
  9. CBF? stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell. 2013 Feb 21; 49(4):632-44.
    View in: PubMed
    Score: 0.016
  10. Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. PLoS Pathog. 2012 Dec; 8(12):e1003085.
    View in: PubMed
    Score: 0.016
  11. A split active site couples cap recognition by Dcp2 to activation. Nat Struct Mol Biol. 2010 Sep; 17(9):1096-101.
    View in: PubMed
    Score: 0.014
  12. A kinetic assay to monitor RNA decapping under single- turnover conditions. Methods Enzymol. 2008; 448:23-40.
    View in: PubMed
    Score: 0.011
  13. SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. PLoS Pathog. 2022 09; 18(9):e1010811.
    View in: PubMed
    Score: 0.008
  14. Fluorescence-Based Activity Screening Assay Reveals Small Molecule Inhibitors of Vaccinia Virus mRNA Decapping Enzyme D9. ACS Chem Biol. 2022 06 17; 17(6):1460-1471.
    View in: PubMed
    Score: 0.008
  15. Identification of recombinant Fabs for structural and functional characterization of HIV-host factor complexes. PLoS One. 2021; 16(5):e0250318.
    View in: PubMed
    Score: 0.007
  16. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 07; 583(7816):459-468.
    View in: PubMed
    Score: 0.007
  17. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. Cell Host Microbe. 2019 07 10; 26(1):86-99.e7.
    View in: PubMed
    Score: 0.006
  18. A Viral Protein Restricts Drosophila RNAi Immunity by Regulating Argonaute Activity and Stability. Cell Host Microbe. 2018 10 10; 24(4):542-557.e9.
    View in: PubMed
    Score: 0.006
  19. CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. EMBO J. 2018 09 14; 37(18).
    View in: PubMed
    Score: 0.006
  20. Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription. Annu Rev Virol. 2017 09 29; 4(1):241-260.
    View in: PubMed
    Score: 0.006
  21. Lineage-Specific Viral Hijacking of Non-canonical E3?Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity. Cell Rep. 2015 May 26; 11(8):1236-50.
    View in: PubMed
    Score: 0.005
  22. A mutually assured destruction mechanism attenuates light signaling in Arabidopsis. Science. 2014 Jun 06; 344(6188):1160-1164.
    View in: PubMed
    Score: 0.004
  23. From systems to structure: bridging networks and mechanism. Mol Cell. 2013 Jan 24; 49(2):222-31.
    View in: PubMed
    Score: 0.004
  24. In support of the BMRB. Nat Struct Mol Biol. 2012 Sep; 19(9):854-60.
    View in: PubMed
    Score: 0.004
  25. Vif hijacks CBF-? to degrade APOBEC3G and promote HIV-1 infection. Nature. 2011 Dec 21; 481(7381):371-5.
    View in: PubMed
    Score: 0.004
  26. An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. J Mol Biol. 2009 Jun 26; 389(5):819-32.
    View in: PubMed
    Score: 0.003
  27. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol Cell Biol. 2008 Dec; 28(24):7476-86.
    View in: PubMed
    Score: 0.003
  28. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell. 2007 Jan 26; 128(2):257-67.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.